Fosun Adgenvax (Chengdu) joins an IPO wave that raised more than US$1.5 billion last year for biotech companies The board of Shanghai Fosun Pharmaceutical approved the spin-off and Hong Kong listing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback